EUVIMEDEUVIMED entdecken
Open Access

Increased frequency and mortality in persons with neurological disorders during COVID-19

Candace M Marsters, Jeffrey A Bakal, Grace Y Lam, Finlay A McAlister, Christopher Power iD

Brain · 05.07.2024 · 147 (7) · 2542-2551

DOI: 10.1093/brain/awae117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 20.04.2024. Verfasst von Candace M Marsters und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2B7, Canada. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Institutes for Health Research, Alberta Innovates, University Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Determining the frequency and outcomes of neurological disorders associated with coronavirus disease 2019 (COVID-19) is imperative for understanding risks and for recognition of emerging neurological disorders. We investigated the susceptibility and impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among persons with premorbid neurological disorders, in addition to the post-infection incidence of neurological sequelae, in a case–control population-based cohort. Using health service data collected between 1 March 2020 and 30 June 2021, we constructed a cohort of SARS-CoV-2 RNA-positive (n = 177 892) and -negative (n = 177 800) adults who were age, sex and comorbidity matched and underwent RT-PCR testing at similar times. COVID-19-associated mortality rates were examined within the cohort. Neurological sequelae were analysed during the acute (<3 months) and the post-acute (3–9 months) phases post-infection. The risk of death was significantly greater in the SARS-CoV-2 RNA-positive (2140 per 100 000 person years) compared with RNA-negative (922 per 100 000 person years) over a follow-up of 9 months, particularly amongst those with premorbid neurological disorders: adjusted odds ratios (95% confidence interval) in persons with a prior history of parkinsonism, 1.65 (1.15–2.37); dementia, 1.30 (1.11–1.52); seizures, 1.91 (1.26–2.87); encephalopathy, 1.82 (1.02–3.23); and stroke, 1.74 (1.05–2.86). There was also a significantly increased risk for diagnosis of new neurological sequelae during the acute time phase after COVID-19, including encephalopathy, 2.0 (1.10–3.64); dementia, 1.36 (1.07–1.73); seizure, 1.77 (1.22–2.56); and brain fog, 1.96 (1.20–3.20). These risks persisted into the post-acute phase after COVID-19, during which inflammatory myopathy (2.57, 1.07–6.15) and coma (1.87, 1.22–2.87) also became significantly increased. Thus, persons with SARS-CoV-2 infection and premorbid neurological disorders are at greater risk of death, and SARS-CoV-2 infection was complicated by increased risk of new-onset neurological disorders in both the acute and post-acute phases of COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nervous System DiseasesHumansMaleFemaleMiddle AgedAgedAdultCase-Control StudiesSARS-CoV-2Cohort StudiesAged, 80 and overComorbidityIncidence

Stichwörter der Autor:innen

COVID-19SARS-CoV-2case–controlneurological complicationsneurological disorderspopulation epidemiology

Autor:innen und Institutionen

  • Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2B7, Canada.
  • Provincial Research Data Services-Alberta Health Services, Edmonton, AB T6G 2B7, Canada.
  • Alberta Strategy for Patient Oriented Research Unit, Edmonton, AB T6G 2C8, Canada.
  • Division of Pulmonology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2B7, Canada.

ORCID-Profile: Christopher Power

Förderung

  • Canadian Institutes for Health Research
  • Alberta Innovates
  • University Hospital Foundation
  • Universities of Alberta
  • Alberta Health Services
  • Woman and Children's Health Research Institute
  • Woman and Children’s Health Research Institute

Zitieren

APA

Marsters, C. M., Bakal, J. A., Lam, G. Y., McAlister, F. A., & Power, C. (2024). Increased frequency and mortality in persons with neurological disorders during COVID-19. Brain, 147(7), 2542-2551. https://doi.org/10.1093/brain/awae117

Vancouver

Marsters CM, Bakal JA, Lam GY, McAlister FA, Power C. Increased frequency and mortality in persons with neurological disorders during COVID-19. Brain. 2024;147(7):2542-2551. doi:10.1093/brain/awae117

BibTeX
@article{Marsters2024,
  author = {Marsters, Candace M and Bakal, Jeffrey A and Lam, Grace Y and McAlister, Finlay A and Power, Christopher},
  title = {Increased frequency and mortality in persons with neurological disorders during COVID-19},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {7},
  pages = {2542--2551},
  doi = {10.1093/brain/awae117}
}
Kostenlos starten →